Sign in
Not yet taking people in United StatesNo phase

Ear nerve stimulation for adults with constipation-type irritable bowel syndrome

Tests ear-based vagus nerve stimulation against a sham device in adults with IBS-C.

Key facts

Who runs it
West Virginia University
Where
Morgantown, United StatesSee the site
Trial code
Registry title
Trans Auricular Vagal Nerve Stimulation in Patients With IBS-C
Status
Not yet recruiting
People taking part
80 people, planned
Started
Jul 2026
Expected to end
Jul 2027
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Transcutaneous Auricular Vagus Nerve Stimulation (ta-VNS)
  • Sham Transcutaneous Auricular Vagus Nerve Stimulation
Record updated
23 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with irritable bowel syndrome with constipation (IBS-C) who were referred to the WVU Department of Gastroenterology and Hepatology. Participants get either real or fake (sham) ear nerve stimulation for 60 days.

Age
18 Years and older
Sex
All
Disease stage
Diagnosis of IBS-C (irritable bowel syndrome, mainly with constipation).
Earlier treatment
People whose IBS-C did not get better with second-line drugs (linaclotide, lubiprostone, plecanatide or tenapanor) or third-line tegaserod cannot join. People who currently use opioids cannot join.

Main reasons for not taking part

  • Pregnancy
  • Known disabling mental illness, problems with thinking or memory, or active substance use disorder
  • Past major bowel or stomach surgery that changed the gut, or past vagotomy (cutting of the vagus nerve)
  • Constipation from another cause, such as opioid use, uncontrolled hypothyroidism or celiac disease
  • Prisoners

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Referred to the WVU Department of Gastroenterology and Hepatology
  • Diagnosis of IBS-C

Who cannot take part

  • Concurrent opioid use
  • Failure of second-line therapy with secretagogues (linaclotide, lubiprostone, plecanatide, or tenapanor)
  • Failure of third-line therapy with tegaserod
  • Known debilitating psychiatric illness
  • Cognitive impairment
  • Active substance use disorder
  • History of major gastrointestinal surgery resulting in luminal alteration
  • History of vagotomy
  • Secondary causes of constipation (e.g., opioid use, uncontrolled hypothyroidism, celiac disease)
  • Pregnancy
  • Prisoners

Where in United States

  • West Virginia University- Gastroenterology and HepatologyMorgantown, United StatesContact: Zain Sobani, MDNot yet recruiting

About the trial

What the trial wants to find out

This study evaluates the efficacy and safety of transcutaneous auricular vagus nerve stimulation (ta-VNS) in adults with constipation-predominant irritable bowel syndrome (IBS-C). Participants will be randomized to receive either active or sham stimulation using a non-invasive auricular device over a 60-day period.

Read full original descriptionShow less

The primary objectives are to assess changes in symptom severity and quality of life using validated instruments, including the IBS Symptom Severity Scale (IBS-SSS) and the IBS Quality of Life questionnaire (IBS-QOL). Secondary assessments include safety and participant compliance.

This study aims to determine whether ta-VNS is an effective non-invasive therapeutic modality for improving symptoms and quality of life in patients with IBS-C.

The 2 groups in the trial

  • Transcutaneous Auricular Vagus Nerve Stimulation (ta-VNS)Treatment being tested

    Participants will receive active transcutaneous auricular vagus nerve stimulation (ta-VNS) using the Parasym device (Parasym Health, Inc., London, UK). The device delivers electrical stimulation to the auricular branch of the vagus nerve via an ear clip. Stimulation will be administered once daily for 30 minutes over 60 days at a consistent time chosen by the participant. Stimulation parameters are set at 25 Hz and 250 microseconds, with intensity adjusted to just below the participant's discomfort threshold (0-36 mA).

  • Sham Transcutaneous Auricular Vagus Nerve StimulationSham treatment, for comparison

    Participants will receive sham stimulation using an identical-appearing Parasym device. The device delivers a brief, low-level electrical output at the start of each session, which ramps down to zero and provides no stimulation for the remainder of the session. Sessions will last 30 minutes daily for 60 days at a consistent time of the participant's choosing. The device will look, feel, and sound identical to the active device to maintain blinding.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Randomized Controlled Trial Evaluating Trans Auricular Vagal Nerve Stimulation in Patients With Irritable Bowel Syndrome Constipation Subtype
Plain-language title
Ear nerve stimulation for adults with constipation-type irritable bowel syndromeGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
23 June 2026